ArticleThe Journal of international medical research2020
Long-term response to second-line afatinib treatment for advanced squamous cell carcinoma non-small cell lung cancer: a rare case report.
Mengyao Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.